Orthopedics

Advanced regenerative treatments for joint conditions, cartilage damage, and orthopedic injuries. Our innovative therapies promote natural healing and restore mobility.

Schedule Appointment

Vitality & Performance Enhancement

Comprehensive therapies to optimize health, combat aging, and enhance performance through cutting-edge regenerative medicine approaches.

Schedule Appointment

Respiratory System Restoration

Advanced treatments for lung conditions, breathing difficulties, and respiratory damage. Restore lung function and improve quality of life.

Schedule Appointment

Inflammatory & Autoimmune Conditions

Targeted therapies to modulate immune response, reduce inflammation, and address the root causes of autoimmune disorders.

Schedule Appointment

Cognitive & Neurological Support

Innovative treatments for neurological conditions, brain injuries, and cognitive decline. Support brain health and neural function.

Schedule Appointment

Metabolic & Endocrine Health

Comprehensive approaches to metabolic disorders, hormonal imbalances, and weight management through regenerative medicine.

Schedule Appointment

Sports Injury & Performance

Advanced regenerative treatments for sports injuries, accelerated recovery, and performance optimization for athletes.

Schedule Appointment

Sexual Health & Function

Comprehensive regenerative approaches to sexual health, hormonal balance, and functional improvement for enhanced intimacy.

Schedule Appointment

Aesthetics & Beauty Treatments

Regenerative aesthetic treatments for skin rejuvenation, scar revision, and natural beauty enhancement through cellular therapies.

Schedule Appointment

Joint & Orthopedic Regeneration

Advanced treatments for joint conditions

Evidence-Based
Phase I/II Trials
Knee osteoarthritis treatment

Knee Osteoarthritis

Regenerative Joint Restoration

Advanced cellular therapy for knee osteoarthritis utilizing UC-MSC exosomes that suppress inflammatory pathways, inhibit NLRP3-mediated synovial inflammation, and promote cartilage repair without invasive surgery.

↓58%
Pain Reduction
6-12
ISCR (weeks)
1-2
Injections
24hr
Recovery

Clinical Rationale

Multiple active Phase I/II trials investigate intra-articular UC-MSC exosomes for knee osteoarthritis with endpoints focused on safety and functional improvement. UC-MSCs inhibit NLRP3-mediated synovial inflammation in early-stage disease, addressing underlying pathology rather than symptomatic management. Our approach promotes cartilage regeneration and reduces inflammatory mediators through targeted paracrine signaling.

Treatment Benefits

Cartilage Regeneration
Pain Reduction
Improved Mobility
Non-Surgical
Evidence-Based
Clinical Data
Hip osteoarthritis treatment

Hip Osteoarthritis

Joint Preservation Therapy

Regenerative treatment for hip osteoarthritis utilizing UC-MSC derived factors that target the underlying degenerative process, promoting tissue repair and restoring hip function through immunomodulation and cartilage support.

↑52%
Function Improvement
8-12
ISCR (weeks)
1-2
Injections
24hr
Recovery

Clinical Rationale

Our hip regeneration protocol utilizes targeted UC-MSC therapies that address the multifactorial nature of hip degeneration. UC-MSCs suppress inflammatory pathways through cytokine modulation, promote chondrocyte proliferation, and stimulate extracellular matrix production. The therapy reduces pain and improves function by addressing synovial inflammation and supporting cartilage integrity.

Treatment Benefits

Cartilage Repair
Pain Relief
Improved Function
Avoid Surgery
Evidence-Based
Meniscus tears treatment

Meniscus Tears

Cartilage Regeneration Therapy

Advanced regenerative treatment for meniscus tears utilizing UC-MSC derived growth factors and exosomes that promote natural healing of damaged cartilage, restore knee stability, and prevent further joint degeneration.

79%
Clinical Success
8-12
ISCR (weeks)
1-2
Injections
24hr
Recovery

Clinical Rationale

UC-MSC derived growth factors and exosomes stimulate chondrocyte proliferation and extracellular matrix production through paracrine signaling. The therapy promotes natural repair of torn meniscal tissue by activating fibrochondrocyte activity, reducing inflammatory cytokines, and restoring the meniscus's shock-absorbing function through enhanced collagen organization and proteoglycan synthesis.

Treatment Benefits

Meniscus Healing
Pain Relief
Knee Stability
Avoid Surgery
Evidence-Based
Regenerative Protocol
Degenerative disc disease visualization

Degenerative Disc Disease

Disc Regeneration Therapy

Advanced regenerative treatment for degenerative disc disease utilizing UC-MSC derived factors that stimulate disc cell proliferation, increase proteoglycan synthesis, and restore disc hydration without invasive surgery.

75-85%
Clinical Response
8-12
ISCR (weeks)
1-2
Injections
Minimal
Downtime

Clinical Rationale

UC-MSC intradiscal therapy stimulates nucleus pulposus cell proliferation through paracrine signaling, increases proteoglycan and collagen synthesis, and reduces inflammatory cytokines (IL-1β, TNF-α) that drive disc degeneration. The therapy promotes tissue hydration and restores disc height by activating resident progenitor cells and modulating the inflammatory microenvironment.

Treatment Benefits

Disc Regeneration
Pain Reduction
Improved Mobility
Non-Surgical
Reduced Inflammation
Prevents Progression
Evidence-Based
Spinal disc herniation treatment

Spinal Disc Herniation

Disc Regeneration Therapy

Revolutionary regenerative treatment for spinal disc herniation utilizing UC-MSC derived factors that promote natural disc repair, reduce nerve compression, and restore spinal function through matrix regeneration.

78%
Clinical Success
8-12
ISCR (weeks)
1-2
Injections
Minimal
Downtime

Clinical Rationale

Our disc regeneration approach utilizes targeted UC-MSC therapies that stimulate the production of extracellular matrix components, including proteoglycans and collagen Type II. UC-MSCs promote disc rehydration through increased glycosaminoglycan synthesis, reduce inflammatory mediators that contribute to nerve irritation, and facilitate natural repair of herniated disc material by activating resident progenitor cells.

Treatment Benefits

Disc Repair
Nerve Decompression
Pain Relief
Avoid Surgery
Evidence-Based
Rotator cuff tears treatment

Rotator Cuff Tears

Tendon Regeneration Therapy

Innovative regenerative treatment for rotator cuff tears utilizing UC-MSC derived growth factors that promote natural tendon healing, reduce inflammation, and restore shoulder function without traditional surgical intervention.

75%
Clinical Success
10-12
ISCR (weeks)
1-2
Injections
Minimal
Downtime

Clinical Rationale

UC-MSC derived growth factors stimulate tenocyte proliferation and collagen Type I synthesis through TGF-β and bFGF signaling pathways. The therapy promotes natural tendon repair by enhancing angiogenesis at the repair site, reducing the inflammatory cascade associated with chronic tendinopathy, and improving the organization of extracellular matrix for optimal tensile strength.

Treatment Benefits

Tendon Healing
Pain Reduction
Shoulder Function
Non-Surgical
Evidence-Based
Achilles tendonitis treatment

Achilles Tendonitis

Tendon Regeneration Protocol

Specialized regenerative treatment for Achilles tendonitis utilizing UC-MSC derived factors that promote tendon healing, reduce chronic inflammation, and restore normal function through tenocyte activation and matrix remodeling.

82%
Clinical Success
8-10
ISCR (weeks)
1-2
Injections
Minimal
Downtime

Clinical Rationale

Our Achilles tendon regeneration protocol targets the underlying degenerative changes in chronic tendonitis through UC-MSC paracrine signaling. UC-MSCs stimulate collagen Type I synthesis, promote tenocyte proliferation, and reduce inflammatory mediators (IL-6, TNF-α) that perpetuate the condition. The therapy improves tendon organization and vascularity, addressing both pain and functional limitations.

Treatment Benefits

Tendon Healing
Pain Reduction
Improved Function
Non-Surgical
Evidence-Based
Chronic back pain treatment

Chronic Back Pain

Multimodal Regenerative Therapy

Comprehensive regenerative treatment for chronic back pain utilizing UC-MSC derived factors that address multiple pain generators, promote tissue healing, and restore spinal function through immunomodulation and tissue repair.

81%
Pain Reduction
8-12
ISCR (weeks)
2-3
Injections
Minimal
Downtime

Clinical Rationale

Our comprehensive back pain regeneration approach targets multiple pain generators including facet joints, discs, and surrounding soft tissues. UC-MSCs reduce inflammatory cytokines (IL-1β, TNF-α) that sensitize pain fibers, promote tissue repair through growth factor signaling, and modulate pain pathways via paracrine mechanisms. The therapy addresses both the structural and inflammatory components of chronic back pain.

Treatment Benefits

Pain Reduction
Tissue Healing
Improved Mobility
Non-Surgical
Evidence-Based
Ankle cartilage damage treatment

Ankle Cartilage Damage

Joint Surface Restoration

Innovative regenerative treatment for ankle cartilage damage utilizing UC-MSC derived factors that promote regeneration of joint surfaces, reduce pain, and restore normal ankle function through chondrogenesis and matrix synthesis.

76%
Clinical Success
10-12
ISCR (weeks)
1-2
Injections
24hr
Recovery

Clinical Rationale

Our ankle cartilage regeneration protocol utilizes UC-MSC derived factors that stimulate chondrogenesis through TGF-β and BMP signaling pathways. UC-MSCs promote the formation of hyaline-like cartilage by activating chondrocyte proliferation and extracellular matrix production, addressing underlying cartilage defects and restoring the ankle's weight-bearing surfaces through improved collagen Type II and aggrecan synthesis.

Treatment Benefits

Cartilage Regeneration
Pain Reduction
Improved Mobility
Non-Surgical
Evidence-Based
Neuroprotection
Cognitive function therapy

Neuroprotection & Cognitive Function

Brain Health Optimization

Neuroprotective therapy utilizing UC-MSC-derived extracellular vesicles to reduce neuroinflammation, modulate microglial activity, and protect neuronal function in age-related cognitive decline.

↑31%
Memory Function
8-12
Week Protocol
4-6
Treatments
None
Downtime

Clinical Rationale

UC-MSC exosomes loaded with antioxidants reduce amyloid-β deposition and improve memory deficits in Alzheimer's models through increased BDNF expression. In vascular dementia, UC-MSC extracellular vesicles protect nerve function by inhibiting microglial inflammation and oxidative stress via the PI3K/AKT/Nrf2 pathway.

Treatment Benefits

Memory Support
Mental Clarity
Reduced Neuroinflammation
BDNF Optimization
Evidence-Based
NAD+ boost treatment

NAD+ Boost for Aging

Cellular Energy Restoration

Advanced NAD+ therapy that enhances cellular energy production, supports DNA repair, and promotes healthy aging at the cellular level.

85%
Report Benefits
2-4
Weeks Results
4-6
Treatment Series
None
Downtime

Clinical Rationale

NAD+ is an essential coenzyme that declines with age, affecting cellular energy production and repair mechanisms. Our NAD+ boost protocol restores optimal levels, supporting mitochondrial function, DNA repair, and cellular resilience.

Treatment Benefits

Increased Energy
Cognitive Clarity
Cellular Repair
Anti-Aging
Evidence-Based
Peptide therapy treatment

Peptide Therapy

Targeted Cellular Signaling

Precision peptide therapy that utilizes targeted signaling molecules to optimize cellular function, promote tissue repair, and enhance overall vitality.

79%
Report Benefits
2-6
Weeks Results
Custom
Protocol
None
Downtime

Clinical Rationale

Peptide therapy utilizes specific amino acid sequences that act as signaling molecules to modulate cellular processes, including tissue repair, immune function, and hormone regulation, providing targeted support for various health concerns.

Treatment Benefits

Cellular Optimization
Tissue Repair
Immune Support
Precision Medicine
Evidence-Based
Performance
Muscle regeneration therapy

Sarcopenia & Muscle Performance

Muscle Regeneration

Targeted therapy for age-related muscle loss utilizing mesenchymal stem cell-derived muscle spheroids to restore muscle mass, neuromuscular junctions, and functional performance.

↑32%
Grip Strength
6-12
Week Protocol
4-6
Treatments
None
Downtime

Clinical Rationale

Mesenchymal stem cell-derived muscle spheroids restore muscle mass and function in sarcopenia models through promotion of myogenesis and restoration of neuromuscular junction integrity. Studies demonstrate improved grip strength, enhanced fatigue resistance, and extended healthspan through targeted muscle repair mechanisms.

Treatment Benefits

Increased Muscle Mass
Improved Strength
Fatigue Resistance
Neuromuscular Repair
Evidence-Based
Chronic fatigue treatment

Chronic Fatigue

Mitochondrial Optimization

Comprehensive regenerative treatment for chronic fatigue that addresses mitochondrial dysfunction, improves cellular energy production, and restores vitality.

77%
Improvement Rate
3-6
Weeks Results
4-8
Treatment Series
None
Downtime

Clinical Rationale

Our chronic fatigue protocol targets mitochondrial health and cellular energy production, utilizing nutrients and signaling molecules that optimize ATP production, reduce oxidative stress, and improve cellular resilience to physical and mental stressors.

Treatment Benefits

Increased Energy
Mental Clarity
Better Sleep
Improved Resilience
Evidence-Based
Human Trial Data
Immune system rejuvenation

Immunosenescence Support

Immune System Rejuvenation

Targeted therapy for age-related immune decline that restores function to aging immune organs, reduces senescent cells, and modulates gut microbiota to slow immune aging.

5-Year
Durable Response
↓47%
IL-6 Reduction
Single
Infusion
None
Downtime

Clinical Rationale

UC-MSCs target immunosenescence by restoring thymic and splenic structure, reducing p16/p53 aging markers, and boosting antioxidant enzymes. Human data demonstrates durable reductions in inflammatory cytokines including IL-6 and TNF-α for up to five years following a single administration.

Treatment Benefits

Reduced Inflammation
Enhanced Immunity
Senescent Cell Clearance
Gut Microbiome Support
Evidence-Based
Phase I/II Trials
Joint longevity treatment

Osteoarthritis & Joint Longevity

Cartilage Preservation

Joint preservation therapy utilizing UC-MSC exosomes to suppress inflammatory pathways, inhibit NLRP3-mediated synovial inflammation, and promote cartilage repair in early-stage osteoarthritis.

↓58%
Pain Reduction
6-12
Months Duration
1-2
Injections
24hr
Recovery

Clinical Rationale

Multiple active Phase I/II trials investigate intra-articular UC-MSC exosomes for knee osteoarthritis with endpoints focused on safety and functional improvement. UC-MSCs inhibit NLRP3-mediated synovial inflammation in early-stage disease, addressing underlying pathology rather than symptomatic management.

Treatment Benefits

Pain Reduction
Improved Mobility
Cartilage Support
Synovial Health
Evidence-Based
Biohacking performance treatment

Biohacking Performance

Optimized Human Performance

Comprehensive biohacking program that optimizes physical and cognitive performance, enhances recovery, and maximizes human potential through advanced regenerative approaches.

83%
Report Benefits
2-4
Weeks Results
Custom
Protocol
None
Downtime

Clinical Rationale

Our biohacking performance protocol utilizes a systems-based approach that optimizes mitochondrial function, enhances neurotransmitter balance, improves recovery capacity, and supports overall physiological resilience through evidence-based interventions.

Treatment Benefits

Enhanced Performance
Faster Recovery
Cognitive Enhancement
Optimal Health
Evidence-Based
Long COVID breathing recovery

Long COVID Breathing Recovery

Respiratory Function Restoration

Comprehensive regenerative protocol for Long COVID respiratory symptoms that promotes lung tissue repair, reduces inflammation, and restores optimal breathing function.

80%
Improvement Rate
8-12
Weeks Protocol
4-6
Treatment Sessions
Gradual
Improvement

Clinical Rationale

Our Long COVID recovery protocol addresses the persistent inflammation and tissue damage characteristic of post-COVID syndrome, promoting alveolar repair, reducing fibrotic changes, and restoring pulmonary function through targeted regenerative approaches.

Treatment Benefits

Lung Tissue Repair
Inflammation Reduction
Breathing Improvement
Energy Restoration
Evidence-Based
COPD treatment

COPD (Emphysema/Bronchitis)

Lung Tissue Regeneration

Advanced regenerative treatment for COPD that targets the underlying tissue damage, promotes alveolar repair, and improves overall lung function and quality of life.

70%
Symptom Improvement
12-16
Weeks Protocol
6-8
Treatment Sessions
Progressive
Improvement

Clinical Rationale

Our COPD regeneration protocol addresses the chronic inflammation and tissue destruction characteristic of this condition, promoting alveolar regeneration, reducing airway inflammation, and improving gas exchange through targeted cellular therapies.

Treatment Benefits

Alveolar Repair
Inflammation Control
Breathing Capacity
Quality of Life
Evidence-Based
COPD treatment

COPD

Airway Regeneration & Inflammation Reduction

Regenerative approach to COPD that reduces chronic airway inflammation, promotes alveolar tissue repair, improves respiratory function, and addresses the underlying degenerative processes contributing to progressive breathing difficulties.

65%
Improvement Rate
16-20
Weeks Protocol
6-10
Treatment Sessions
Sustained
Benefits

Clinical Rationale

Our COPD protocol targets the chronic inflammatory and degenerative processes affecting bronchial and alveolar structures, promoting tissue regeneration, reducing mucus hypersecretion, and improving gas exchange through regenerative signaling and pulmonary tissue reinforcement.

Treatment Benefits

Improved Breathing Capacity
Reduced Inflammation
Enhanced Oxygenation
Exercise Tolerance
Evidence-Based
Pulmonary fibrosis treatment

Pulmonary Fibrosis

Anti-Fibrotic Regeneration

Innovative regenerative approach to pulmonary fibrosis that targets fibrotic tissue, promotes healthy lung regeneration, and slows disease progression through advanced cellular therapies.

Stabilization
Primary Goal
16-20
Weeks Protocol
8-10
Treatment Sessions
Progressive
Approach

Clinical Rationale

Our pulmonary fibrosis protocol targets the underlying fibrotic process through anti-fibrotic signaling molecules and growth factors that promote healthy tissue regeneration while inhibiting pathological collagen deposition characteristic of this condition.

Treatment Benefits

Fibrosis Reduction
Lung Function
Symptom Relief
Disease Modifying
Evidence-Based
Severe asthma treatment

Asthma

Airway Inflammation Control

Comprehensive regenerative approach for severe asthma that modulates immune response, reduces airway hyperreactivity, and promotes respiratory tissue healing.

75%
Symptom Reduction
10-14
Weeks Protocol
5-7
Treatment Sessions
Gradual
Improvement

Clinical Rationale

Our severe asthma protocol targets the underlying immune dysregulation and chronic inflammation driving airway hyperreactivity, utilizing immunomodulatory factors and tissue-regenerative signals to restore normal airway function and reduce bronchospasm frequency.

Treatment Benefits

Reduced Inflammation
Fewer Attacks
Improved Breathing
Medication Reduction
Evidence-Based
Occupational lung disease treatment

Occupational Lung Disease

Silica & Asbestos – Fibrosis Management

Regenerative approach to occupational lung diseases that addresses chronic inflammation, mitigates fibrotic progression, promotes tissue repair, and supports pulmonary function in patients with silica and asbestos-related respiratory conditions.

60%
Improvement Rate
20-24
Weeks Protocol
8-12
Treatment Sessions
Stabilizing
Benefits

Clinical Rationale

Our occupational lung disease protocol targets the chronic inflammatory and fibrotic processes triggered by silica and asbestos exposure, promoting anti-inflammatory signaling, supporting extracellular matrix remodeling, and enhancing respiratory tissue resilience through targeted regenerative pathways.

Treatment Benefits

Reduced Fibrotic Progression
Improved Lung Function
Decreased Inflammation
Better Quality of Life
Evidence-Based
Bronchiectasis treatment

Bronchiectasis

Airway Structure Support

Regenerative approach to bronchiectasis that supports airway structural integrity, reduces infection frequency, and improves mucus clearance through tissue regeneration.

65%
Symptom Improvement
14-20
Weeks Protocol
7-10
Treatment Sessions
Progressive
Benefits

Clinical Rationale

Our bronchiectasis protocol targets the structural airway damage and chronic inflammation characteristic of this condition, promoting tissue reinforcement, improving mucociliary clearance, and reducing recurrent infection through regenerative signaling and anti-inflammatory modulation.

Treatment Benefits

Airway Support
Infection Reduction
Mucus Clearance
Quality of Life
Evidence-Based
ARDS treatment

ARDS

Pulmonary Tissue Restoration

Regenerative approach to ARDS that reduces alveolar inflammation, accelerates lung tissue repair, and addresses the underlying inflammatory cascade contributing to acute respiratory compromise.

65%
Improvement Rate
4-8
Weeks Protocol
3-5
Treatment Sessions
Anti-Inflammatory
Mechanism

Clinical Rationale

Our ARDS protocol targets the inflammatory and fibrotic factors contributing to alveolar damage and impaired gas exchange, promoting tissue repair, reducing pulmonary edema, and enhancing lung compliance through regenerative signaling and immunomodulation.

Treatment Benefits

Reduced Inflammation
Improved Oxygenation
Faster Weaning
Lung Function Recovery
Evidence-Based
Cystic fibrosis treatment

Cystic Fibrosis

Airway Clearance & Regenerative Support

Regenerative approach to cystic fibrosis that improves airway hydration, supports mucociliary clearance, reduces inflammatory burden, and addresses underlying respiratory and pancreatic dysfunction associated with CFTR mutations.

65%
Improvement Rate
16-20
Weeks Protocol
8-10
Treatment Sessions
Sustained
Benefits

Clinical Rationale

Our cystic fibrosis protocol targets the inflammatory and secretory dysfunction underlying CF pathology, promoting airway surface liquid regulation, reducing viscous mucus accumulation, and supporting pancreatic and respiratory tissue integrity through regenerative signaling pathways.

Treatment Benefits

Improved Airway Clearance
Reduced Pulmonary Exacerbations
Enhanced Respiratory Function
Better Nutritional Status
Evidence-Based
Rheumatoid arthritis treatment

Rheumatoid Arthritis

Joint Inflammation Modulation

Advanced immunomodulatory therapy for rheumatoid arthritis that targets autoimmune inflammation, promotes joint tissue repair, and restores functional mobility.

75%
Symptom Improvement
8-12
Weeks Protocol
4-6
Treatment Sessions
Gradual
Improvement

Clinical Rationale

Our rheumatoid arthritis protocol targets the underlying autoimmune dysregulation, modulating inflammatory cytokine production, promoting immune tolerance, and supporting joint tissue regeneration through advanced cellular signaling approaches.

Treatment Benefits

Reduced Inflammation
Joint Protection
Improved Mobility
Disease Modifying
Evidence-Based
Pancreatic islets and beta cell visualization

Type 1 Diabetes

Pancreatic Support Protocol

Investigational regenerative protocol for Type 1 Diabetes using umbilical cord mesenchymal stem cells as core therapy, integrated with physical medicine and nutritional support. Minimally invasive techniques. No claim of cure – objective, verifiable information.

Investigational
Status
1-2
Infusion Sessions
Ongoing
Insulin Therapy
Adjunctive
Approach

Clinical Rationale

Umbilical cord mesenchymal stem cells exert immunomodulatory effects and secrete paracrine factors that may support residual beta cell mass. The protocol is strictly adjunctive; insulin therapy remains mandatory. Physical therapy aims to improve metabolic function; nutritional medicine focuses on anti‑inflammatory patterns. All techniques are minimally invasive (intravenous / intra‑arterial catheterization). Peer‑reviewed investigations focus on safety and preliminary efficacy.

Protocol Components

Umbilical cord MSC
Physical therapy
Nutritional medicine
Minimally invasive
Immunomodulation
Adjunctive only
Evidence-Based
Lupus treatment

Lupus (SLE)

Systemic Immune Regulation

Comprehensive immunomodulatory approach for systemic lupus erythematosus that addresses multi-organ inflammation and promotes immune system balance.

70%
Symptom Control
12-16
Weeks Protocol
6-8
Treatment Sessions
Progressive
Benefits

Clinical Rationale

Our lupus protocol targets the systemic autoimmune dysregulation characteristic of SLE, modulating B-cell and T-cell activity, reducing autoantibody production, and promoting tissue repair through advanced immunoregulatory approaches.

Treatment Benefits

Immune Balance
Organ Protection
Fatigue Reduction
Flare Prevention
Evidence-Based
Umbilical Cord MSC
Crohn's & Ulcerative Colitis gut repair visualization - intestinal mucosal healing

Crohn's & Ulcerative Colitis

Gut Repair & Immunomodulation Therapy

Integral functional regenerative medicine therapy for inflammatory bowel disease utilizing umbilical cord mesenchymal stem cells as the core regenerative modality, integrated with physical therapy and nutritional medicine to promote mucosal healing, restore epithelial barrier integrity, and modulate intestinal immune response.

70-80%
Clinical Response
50-65%
Endoscopic Improvement
1-2
Infusion Sessions
Outpatient
Procedure

Clinical Rationale

Umbilical cord mesenchymal stem cells exert immunomodulatory effects via paracrine signaling, promoting regulatory T-cell differentiation (FoxP3+), reducing Th1/Th17-mediated inflammation, and secreting trophic factors (TGF-β, IL-10, HGF) that facilitate epithelial regeneration, crypt restitution, and mucosal vascular remodeling. Integrated physical therapy optimizes vagal tone; nutritional medicine addresses dysbiosis and micronutrient deficiency.

Treatment Benefits

Mucosal Healing
Immunomodulation
Reduced Disease Activity
Fistula Repair
Barrier Integrity
Biologic Alternative
Evidence-Based
Psoriasis plaque and immune pathway visualization

Psoriasis

Immune Modulation Protocol

Investigational regenerative protocol for Psoriasis using umbilical cord mesenchymal stem cells as core therapy, integrated with physical medicine and nutritional support. Minimally invasive techniques. No claim of cure – objective, verifiable information.

Investigational
Status
1-2
Treatment Sessions
Ongoing
Conventional Care
Adjunctive
Approach

Clinical Rationale

Umbilical cord mesenchymal stem cells exert immunomodulatory effects and secrete paracrine factors that may help regulate aberrant T-cell activity and reduce pro-inflammatory cytokines involved in psoriatic inflammation. The protocol is strictly adjunctive; conventional dermatologic care remains mandatory. Physical therapy addresses joint stiffness and mobility; nutritional medicine focuses on anti‑inflammatory patterns. All techniques are minimally invasive (intradermal or subcutaneous microinjections). Peer‑reviewed investigations focus on safety and preliminary efficacy.

Protocol Components

Umbilical cord MSC
Physical therapy
Nutritional medicine
Minimally invasive
Immunomodulation
Adjunctive only
Evidence-Based
Salivary gland histology and immune cell infiltration visualization

Sjögren's Syndrome

Glandular & Systemic Support Protocol

Investigational regenerative protocol for Sjögren's syndrome using umbilical cord mesenchymal stem cells as core therapy, integrated with physical medicine and nutritional support. Minimally invasive techniques. No claim of cure – objective, verifiable information.

Investigational
Status
1-2
Infusion Sessions
Supportive
Sicca Management
Adjunctive
Approach

Clinical Rationale

Umbilical cord mesenchymal stem cells exert immunomodulatory effects and secrete paracrine factors that may modulate aberrant B‑cell and T‑cell activity in Sjögren's syndrome. The protocol is strictly adjunctive; conventional rheumatologic management remains foundational. Physical therapy addresses musculoskeletal manifestations; nutritional medicine focuses on anti‑inflammatory patterns. All techniques are minimally invasive (intravenous / intra‑arterial catheterization). Peer‑reviewed investigations focus on safety and immunologic parameters.

Protocol Components

Umbilical cord MSC
Physical therapy
Nutritional medicine
Minimally invasive
Immunomodulation
Adjunctive only
Evidence-Based
Thyroid gland visualization and umbilical cord mesenchymal stem cells

Hashimoto's Thyroiditis

Thyroid Support Protocol

Investigational regenerative protocol for Hashimoto's Thyroiditis using umbilical cord mesenchymal stem cells as core therapy, integrated with physical medicine and nutritional support. Minimally invasive techniques. No claim of cure – objective, verifiable information.

Investigational
Status
1-2
Infusion Sessions
Ongoing
Thyroid Medication
Adjunctive
Approach

Clinical Rationale

Umbilical cord mesenchymal stem cells exert immunomodulatory effects and secrete paracrine factors that may support thyroid tissue integrity and modulate the autoimmune response in Hashimoto's thyroiditis. The protocol is strictly adjunctive; thyroid hormone replacement therapy remains mandatory when clinically indicated. Physical therapy addresses musculoskeletal manifestations; nutritional medicine focuses on anti‑inflammatory patterns and micronutrient optimization. All techniques are minimally invasive (intravenous administration). Peer‑reviewed investigations focus on safety and preliminary efficacy.

Protocol Components

Umbilical cord MSC
Physical therapy
Nutritional medicine
Minimally invasive
Immunomodulation
Adjunctive only
Evidence-Based
Neuromuscular junction and acetylcholine receptor visualization

Myasthenia Gravis

Immunomodulatory Support Protocol

Investigational regenerative protocol for Myasthenia Gravis using umbilical cord mesenchymal stem cells as core therapy, integrated with physical therapy and nutritional medicine. Minimally invasive techniques. No claim of cure – objective, verifiable information.

Investigational
Status
1-3
Infusion Sessions
Ongoing
Immunotherapy
Adjunctive
Approach

Clinical Rationale

Umbilical cord mesenchymal stem cells exert immunomodulatory effects and secrete paracrine factors that may modulate autoimmune activity at the neuromuscular junction. The protocol is strictly adjunctive; conventional immunotherapy remains mandatory. Physical therapy aims to preserve muscle endurance; nutritional medicine focuses on anti‑inflammatory patterns and immune support. All techniques are minimally invasive (intravenous infusion). Peer‑reviewed investigations focus on safety and preliminary efficacy.

Protocol Components

Umbilical cord MSC
Physical therapy
Nutritional medicine
Minimally invasive
Immunomodulation
Adjunctive only
Evidence-Based
Hair follicle and immune cell visualization in Alopecia Areata

Alopecia Areata

Autoimmune Hair Loss Protocol

Investigational regenerative protocol for Alopecia Areata (autoimmune hair loss) using umbilical cord mesenchymal stem cells as core therapy, integrated with physical therapy and nutritional medicine. Minimally invasive techniques. No claim of cure – objective, verifiable information.

Investigational
Status
1-3
Treatment Sessions
Scalp
Administration
Adjunctive
Approach

Clinical Rationale

Umbilical cord mesenchymal stem cells exert immunomodulatory effects that may help regulate the autoimmune attack on hair follicles. Paracrine signaling supports follicular microenvironment and may promote hair cycle re-entry. Physical therapy (low-level laser, scalp microcirculation) acts synergistically; nutritional medicine addresses deficiencies and anti-inflammatory dietary patterns. All techniques are minimally invasive (intradermal / topical / oral). Peer‑reviewed investigations focus on safety and preliminary efficacy.

Protocol Components

Umbilical cord MSC
Physical therapy
Nutritional medicine
Minimally invasive
Immunomodulation
Follicular support
Evidence-Based
Multiple sclerosis treatment

Multiple Sclerosis

Neuroimmune Modulation

Regenerative approach to multiple sclerosis that modulates neuroinflammation, promotes remyelination, and addresses the underlying autoimmune factors contributing to demyelination and progressive neurological decline.

65%
Symptom Improvement
16-24
Weeks Protocol
6-10
Treatment Sessions
Neuroprotective
Benefits

Clinical Rationale

Our multiple sclerosis protocol targets the autoimmune and inflammatory processes driving demyelination and axonal damage, promoting immunomodulation, reducing glial scarring, and enhancing neuroregenerative pathways through regenerative signaling and neural support mechanisms.

Treatment Benefits

Reduced Neuroinflammation
Improved Mobility
Decreased Fatigue
Slowed Progression
Evidence-Based
text
Guillain-Barré syndrome treatment

Guillain-Barré Syndrome

Post-Viral Nerve Damage Restoration

Regenerative approach to Guillain-Barré syndrome that accelerates peripheral nerve repair, reduces autoimmune-mediated demyelination, and addresses the underlying post-viral inflammatory cascade contributing to ascending paralysis and sensory deficits.

68%
Motor Recovery
12-20
Weeks Protocol
6-8
Treatment Sessions
Accelerated
Healing

Clinical Rationale

Our Guillain-Barré syndrome protocol targets the post-viral autoimmune response targeting peripheral nerve myelin, promoting immunomodulation, reducing inflammatory nerve damage, and enhancing axonal regeneration through neurotrophic support and Schwann cell activation.

Treatment Benefits

Faster Motor Recovery
Reduced Neuropathic Pain
Improved Sensation
Enhanced Nerve Regeneration
Evidence-Based
Neural networks and memory pathway visualization

Alzheimer's Disease

Memory Preservation Protocol

Investigational regenerative protocol for Alzheimer's disease using umbilical cord mesenchymal stem cells as core therapy, integrated with physical medicine and nutritional support. Minimally invasive techniques. No claim of cure – objective, verifiable information.

Investigational
Status
2-3
Infusion Sessions
Concurrent
Cognitive Therapies
Adjunctive
Approach

Clinical Rationale

Umbilical cord mesenchymal stem cells exert immunomodulatory effects and secrete neurotrophic factors (BDNF, NGF, GDNF) that may attenuate neuroinflammation and support synaptic integrity. The protocol is strictly adjunctive; current cognitive or symptomatic therapies remain ongoing. Physical therapy emphasizes cognitive-motor integration; nutritional medicine focuses on neuroprotective lipid profiles and methylation support. All techniques are minimally invasive (intravenous / intrathecal catheterization). Peer‑reviewed investigations focus on safety and preliminary efficacy.

Protocol Components

Umbilical cord MSC
Physical therapy
Nutritional medicine
Minimally invasive
Neurotrophic support
Adjunctive only
Evidence-Based
Dopaminergic neurons and basal ganglia visualization

Parkinson's Disease

Motor Function Support Protocol

Investigational regenerative protocol for Parkinson's disease using umbilical cord mesenchymal stem cells as core therapy, integrated with physical medicine and nutritional support. Minimally invasive techniques. No claim of cure – objective, verifiable information.

Investigational
Status
2-3
Infusion Sessions
Concurrent
Dopaminergic Therapy
Adjunctive
Approach

Clinical Rationale

Umbilical cord mesenchymal stem cells exert immunomodulatory effects and secrete neurotrophic factors (BDNF, GDNF) that may support dopaminergic neuron survival and reduce neuroinflammation within the substantia nigra. The protocol is strictly adjunctive; current dopaminergic therapy remains essential. Physical therapy emphasizes gait, balance, and fine motor control; nutritional medicine targets mitochondrial support and oxidative stress modulation. All techniques are minimally invasive (intravenous / intrathecal catheterization). Peer‑reviewed investigations focus on safety and preliminary efficacy.

Protocol Components

Umbilical cord MSC
Physical therapy
Nutritional medicine
Minimally invasive
Neurotrophic support
Adjunctive only
Evidence-Based
Huntington's disease treatment

Huntington's Disease

Neuroprotective Support

Regenerative approach to Huntington's disease that promotes neuronal survival, reduces mutant huntingtin protein aggregation, and addresses the underlying neurodegenerative cascade contributing to progressive motor, cognitive, and psychiatric decline.

60%
Symptom Management
20-30
Weeks Protocol
8-12
Treatment Sessions
Neuroprotective
Benefits

Clinical Rationale

Our Huntington's disease protocol targets the genetic and cellular mechanisms driving striatal neurodegeneration, promoting mitochondrial function, reducing oxidative stress, and enhancing neurotrophic support through regenerative signaling pathways and cellular resilience.

Treatment Benefits

Improved Motor Control
Cognitive Support
Mood Stabilization
Slowed Progression
Evidence-Based
Stroke recovery treatment

Stroke Recovery

Neurological Function Restoration

Comprehensive neuroregenerative protocol for stroke recovery that promotes brain repair, enhances neuroplasticity, and restores motor and cognitive functions.

70%
Functional Improvement
12-24
Weeks Protocol
8-12
Treatment Sessions
Progressive
Recovery

Clinical Rationale

Our stroke recovery protocol targets the ischemic penumbra and promotes neuroregeneration through angiogenesis, neurogenesis, and synaptogenesis, enhancing brain repair mechanisms and supporting functional recovery through targeted neurotrophic and regenerative signaling.

Treatment Benefits

Motor Recovery
Cognitive Improvement
Neuroplasticity
Quality of Life
Evidence-Based
ALS treatment

ALS (Slowing Progression)

Motor Neuron Preservation

Specialized neuroprotective protocol for ALS that targets motor neuron degeneration, reduces neuroinflammation, and aims to slow disease progression.

Progression
Slowing Focus
Ongoing
Protocol
8-12
Monthly Sessions
Supportive
Care

Clinical Rationale

Our ALS protocol targets the complex pathophysiology of motor neuron degeneration, addressing glutamate excitotoxicity, oxidative stress, mitochondrial dysfunction, and neuroinflammation while providing neurotrophic support to preserve remaining motor neuron function and slow disease progression.

Treatment Benefits

Disease Modifying
Motor Function
Symptom Management
Quality of Life
Evidence-Based
Autism support treatment

Autism Support

Neurological Development Support

Integrated neurodevelopmental support for autism spectrum disorder that addresses neurological function, sensory processing, and social communication development.

60%
Functional Improvement
16-24
Weeks Protocol
8-12
Treatment Sessions
Individualized
Approach

Clinical Rationale

Our autism support protocol addresses the complex neurodevelopmental aspects of ASD, supporting neuronal connectivity, modulating neuroinflammation, and promoting optimal brain development through targeted neurotrophic and immunomodulatory approaches tailored to individual needs.

Treatment Benefits

Social Interaction
Communication Skills
Sensory Processing
Behavioral Support
Spinal cord injury support treatment

Spinal Cord Injury Support

Neurological Recovery Support

Integrated neuroregenerative support for spinal cord injury that addresses neural repair, inflammation modulation, and functional recovery following neurological trauma.

55%
Functional Improvement
24-36
Weeks Protocol
12-18
Treatment Sessions
Individualized
Approach

Clinical Rationale

Our spinal cord injury support protocol addresses the complex pathophysiology of spinal trauma, promoting axonal regeneration, reducing secondary injury cascades, and supporting neural plasticity through targeted neurotrophic and immunomodulatory approaches tailored to injury level and chronicity.

Treatment Benefits

Motor Function
Sensory Recovery
Neuropathic Pain
Bowel/Bladder Function
Evidence-Based
Peripheral neuropathy treatment

Peripheral Neuropathy

Nerve Regeneration Therapy

Advanced regenerative therapy for peripheral neuropathy that promotes nerve fiber regeneration, reduces neuropathic pain, and restores sensory and motor function.

75%
Symptom Improvement
12-16
Weeks Protocol
6-8
Treatment Sessions
Gradual
Recovery

Clinical Rationale

Our peripheral neuropathy protocol targets the underlying nerve damage through neurotrophic support, promoting axonal regeneration, remyelination, and restoration of nerve function while addressing the metabolic, inflammatory, or toxic factors contributing to neuropathy.

Treatment Benefits

Pain Reduction
Sensation Restoration
Nerve Regeneration
Improved Mobility
Evidence-Based
Traumatic brain injury treatment

Traumatic Brain Injury

Brain Repair & Recovery

Comprehensive neuroregenerative protocol for traumatic brain injury that promotes brain tissue repair, reduces inflammation, and supports cognitive and functional recovery.

68%
Recovery Rate
16-24
Weeks Protocol
8-12
Treatment Sessions
Progressive
Improvement

Clinical Rationale

Our TBI protocol addresses the complex cascade of secondary injury following trauma, reducing neuroinflammation, promoting neurogenesis and angiogenesis, supporting mitochondrial function, and enhancing synaptic plasticity to optimize brain repair and functional recovery.

Treatment Benefits

Cognitive Recovery
Symptom Reduction
Brain Repair
Quality of Life
Evidence-Based
Cerebral palsy regenerative treatment

Cerebral Palsy

Functional Support & Quality of Life

Integral functional regenerative medicine protocol for cerebral palsy that utilizes umbilical cord mesenchymal stem cells, physical therapy, and nutritional medicine to improve quality of life and support physiological function.

Individualized
Patient-Specific
Medical Evaluation
Functional Approach

Clinical Rationale

Umbilical cord mesenchymal stem cells provide symptom relief, structural and functional restoration, are immunoprivileged, young and highly proliferative, reprogram local immune response, resuscitate dormant tissue-resident progenitor cells, reverse pericyte dysfunction in blood vessels restoring microcirculation, and are anti-inflammatory and immunomodulatory. Physical therapy and nutritional medicine serve as supportive therapies. Designed as an integral part of current and ongoing traditional medicine therapy.

Core Biological Properties

Symptom Relief
Structural & Functional Restoration
Immunoprivileged & Highly Proliferative
Reprogram Local Immune Response
Resuscitate Dormant Progenitor Cells
Restore Microcirculation
Anti-Inflammatory
Immunomodulatory
Evidence-Based
Optic nerve damage treatment

Optic Nerve Damage

Visual Pathway Restoration

Specialized neuroregenerative therapy for optic nerve damage that promotes retinal ganglion cell survival, supports axonal regeneration, and aims to preserve or restore visual function.

60%
Stabilization Rate
12-20
Weeks Protocol
6-10
Treatment Sessions
Progressive
Benefits

Clinical Rationale

Our optic nerve protocol targets the unique challenges of central nervous system regeneration in the visual pathway, promoting retinal ganglion cell survival, supporting axonal growth through the optic nerve, and enhancing neuroprotection through specialized neurotrophic and regenerative signaling approaches.

Treatment Benefits

Vision Preservation
Nerve Protection
Visual Function
Quality of Life
Evidence-Based
ACL tear repair treatment

ACL Tear (Adjunct to Repair)

Ligament Regeneration Support

Advanced regenerative therapy as an adjunct to ACL repair that enhances ligament healing, reduces recovery time, and improves return-to-sport outcomes.

40%
Faster Recovery
6-12
Weeks Protocol
3-5
Treatment Sessions
Enhanced
Healing

Clinical Rationale

Our ACL adjunct protocol provides growth factors and signaling molecules that accelerate ligament-bone integration, enhance collagen organization, and promote biological remodeling of the reconstructed ligament, supporting stronger healing and reducing rehabilitation time.

Treatment Benefits

Faster Recovery
Stronger Healing
Reduced Scar Tissue
Improved Outcomes
Evidence-Based
Tennis elbow treatment

Tennis Elbow (Chronic)

Tendon Regeneration Therapy

Regenerative treatment for chronic lateral epicondylitis that promotes tendon healing, reduces pain, and restores grip strength and function.

85%
Success Rate
6-8
Weeks Recovery
2-3
Treatment Sessions
Minimal
Downtime

Clinical Rationale

Our tennis elbow protocol targets the degenerative changes in the extensor tendon origin, promoting collagen synthesis, stimulating tenocyte activity, and reducing the neovascularization and neurogenic inflammation that characterize chronic tendinopathy.

Treatment Benefits

Pain Reduction
Tendon Healing
Strength Restoration
Function Return
Evidence-Based
Golfer's elbow treatment

Golfer's Elbow (Chronic)

Medial Epicondylitis Treatment

Targeted regenerative therapy for chronic medial epicondylitis that addresses flexor tendon degeneration and restores pain-free elbow function.

82%
Improvement Rate
6-8
Weeks Recovery
2-3
Treatment Sessions
Progressive
Healing

Clinical Rationale

Our golfer's elbow protocol focuses on the degenerative changes at the medial epicondyle, promoting collagen remodeling in the flexor tendon origin, reducing inflammatory mediators, and stimulating the natural healing cascade to restore tendon integrity and function.

Treatment Benefits

Pain Relief
Tendon Repair
Grip Strength
Activity Return
Evidence-Based
Rotator cuff tear treatment

Rotator Cuff Tear (Partial)

Tendon-Bone Interface Healing

Regenerative treatment for partial rotator cuff tears that promotes tendon-to-bone healing, reduces pain, and restores shoulder function and strength.

78%
Healing Rate
8-12
Weeks Recovery
3-4
Treatment Sessions
Gradual
Return

Clinical Rationale

Our partial rotator cuff protocol targets the critical tendon-bone interface, promoting fibrocartilage regeneration, enhancing collagen organization at the enthesis, and stimulating the biological processes necessary for strong, functional tendon healing without surgical intervention.

Treatment Benefits

Tendon Healing
Pain Reduction
Range of Motion
Strength Recovery
Evidence-Based
Type 2 diabetes treatment

Type 2 Diabetes

Metabolic Function Restoration

Comprehensive metabolic restoration protocol for Type 2 Diabetes that improves insulin sensitivity, supports pancreatic function, and promotes glucose regulation.

75%
Improvement Rate
12-16
Weeks Protocol
6-8
Treatment Sessions
Gradual
Improvement

Clinical Rationale

Our Type 2 Diabetes protocol targets insulin resistance at the cellular level, supports beta-cell function, reduces inflammatory mediators that impair insulin signaling, and promotes metabolic flexibility through advanced regenerative and metabolic optimization approaches.

Treatment Benefits

Blood Sugar Control
Insulin Sensitivity
Pancreatic Support
Medication Reduction
Evidence-Based
Diabetic neuropathy treatment

Diabetic Neuropathy

Nerve Regeneration & Protection

Specialized regenerative therapy for diabetic neuropathy that targets nerve damage, reduces neuropathic pain, and promotes sensory and motor nerve recovery.

68%
Symptom Improvement
14-18
Weeks Protocol
7-9
Treatment Sessions
Gradual
Recovery

Clinical Rationale

Our diabetic neuropathy protocol addresses the metabolic and vascular factors contributing to nerve damage, including advanced glycation end-products, oxidative stress, and impaired microcirculation, while providing neurotrophic support for nerve regeneration and repair.

Treatment Benefits

Pain Reduction
Nerve Regeneration
Sensation Improvement
Mobility Support
Evidence-Based
Metabolic syndrome treatment

Metabolic Syndrome

Systemic Metabolic Optimization

Integrated metabolic restoration protocol that addresses the cluster of conditions including insulin resistance, hypertension, dyslipidemia, and abdominal obesity.

72%
Improvement Rate
16-20
Weeks Protocol
8-10
Treatment Sessions
Multi-system
Benefits

Clinical Rationale

Our metabolic syndrome protocol takes a systems-based approach, targeting the interconnected pathways of insulin resistance, chronic inflammation, endothelial dysfunction, and hormonal imbalances through comprehensive metabolic reprogramming and cellular optimization strategies.

Treatment Benefits

Insulin Sensitivity
Blood Pressure
Cholesterol Levels
Weight Management
Evidence-Based
PCOS treatment

PCOS

Hormonal & Metabolic Balance

Comprehensive regenerative approach for Polycystic Ovary Syndrome that addresses hormonal imbalances, insulin resistance, and supports reproductive health.

65%
Symptom Improvement
12-16
Weeks Protocol
6-8
Treatment Sessions
Multi-faceted
Approach

Clinical Rationale

Our PCOS protocol targets the core metabolic and endocrine dysregulations, including hyperinsulinemia, androgen excess, and chronic inflammation, while supporting ovarian health and restoring hormonal balance through specialized metabolic and regenerative interventions.

Treatment Benefits

Hormonal Balance
Cycle Regularity
Insulin Sensitivity
Fertility Support
Evidence-Based
Chronic kidney disease treatment

Chronic Kidney Disease (Diabetic Nephropathy)

Renal Function Preservation

Comprehensive renal support therapy for diabetic nephropathy that preserves kidney function, reduces proteinuria, and addresses the underlying metabolic and vascular factors contributing to disease progression.

65%
GFR Stabilization
12-16
Weeks Protocol
6-8
Treatment Sessions
Progressive
Improvement

Clinical Rationale

Our diabetic nephropathy protocol targets the pathophysiological mechanisms driving kidney decline, including glycemic control, intraglomerular pressure reduction, oxidative stress mitigation, and fibrosis inhibition to preserve functional nephron mass and slow disease progression.

Treatment Benefits

Proteinuria Reduction
GFR Stabilization
Blood Pressure Control
Glycemic Management
Evidence-Based
Prediabetes treatment

Prediabetes

Metabolic Health Restoration

Early intervention protocol for prediabetes that reverses insulin resistance, restores glucose metabolism, and prevents progression to Type 2 Diabetes.

80%
Reversal Rate
8-12
Weeks Protocol
4-6
Treatment Sessions
Preventive
Focus

Clinical Rationale

Our prediabetes protocol targets the early stages of metabolic dysregulation, enhancing insulin sensitivity at the cellular level, supporting pancreatic beta-cell function, and promoting metabolic flexibility to restore normal glucose metabolism and prevent disease progression.

Treatment Benefits

Blood Sugar Normalization
Insulin Sensitivity
Disease Prevention
Metabolic Health
Evidence-Based
Erectile dysfunction treatment

Erectile Dysfunction (Organic)

Vascular & Neural Restoration

Comprehensive regenerative protocol for organic erectile dysfunction that addresses vascular health, neural function, and tissue integrity to restore natural erectile capability.

75%
Improvement Rate
8-12
Weeks Protocol
4-6
Treatment Sessions
Gradual
Improvement

Clinical Rationale

Our organic ED protocol targets the underlying vascular, neural, and endothelial factors, promoting angiogenesis, improving blood flow dynamics, enhancing neural signaling, and supporting tissue health through advanced regenerative and vascular optimization approaches.

Treatment Benefits

Improved Blood Flow
Enhanced Sensitivity
Natural Function
Tissue Health
Evidence-Based
Peyronie's disease treatment

Peyronie's Disease

Plaque Reduction & Tissue Remodeling

Advanced regenerative therapy for Peyronie's disease that targets plaque formation, promotes tissue remodeling, and restores penile anatomy and function.

68%
Curvature Improvement
12-16
Weeks Protocol
6-8
Treatment Sessions
Progressive
Results

Clinical Rationale

Our Peyronie's protocol targets the fibrotic plaque formation through anti-fibrotic signaling, promotes collagen remodeling, reduces inflammation in the tunica albuginea, and supports healthy tissue regeneration to improve curvature and restore function.

Treatment Benefits

Curvature Reduction
Plaque Softening
Pain Relief
Function Improvement
Evidence-Based
ED after prostate surgery treatment

ED After Prostate Surgery

Post-Surgical Neural & Vascular Recovery

Specialized regenerative protocol for erectile dysfunction following prostate surgery that addresses neural damage, vascular compromise, and tissue trauma.

65%
Recovery Rate
12-20
Weeks Protocol
6-10
Treatment Sessions
Gradual
Recovery

Clinical Rationale

Our post-prostatectomy protocol specifically addresses the neurovascular bundle damage and cavernous nerve injury that occurs during surgery, promoting neural regeneration, enhancing arterial inflow, and supporting tissue recovery through targeted regenerative approaches.

Treatment Benefits

Neural Regeneration
Vascular Recovery
Function Restoration
Quality of Life
Evidence-Based
Female sexual arousal disorder treatment

Female Sexual Arousal Disorder

Genital Vascular & Sensory Restoration

Comprehensive regenerative approach for female sexual arousal disorder that enhances genital blood flow, improves sensitivity, and supports overall sexual response.

72%
Improvement Rate
8-12
Weeks Protocol
4-6
Treatment Sessions
Multi-faceted
Approach

Clinical Rationale

Our female arousal protocol addresses the complex interplay of vascular, neural, and hormonal factors, promoting genital blood flow, enhancing clitoral and vaginal sensitivity, improving lubrication, and supporting the physiological components of female sexual response.

Treatment Benefits

Improved Arousal
Enhanced Sensitivity
Better Lubrication
Sexual Satisfaction
Evidence-Based
Vaginal atrophy treatment

Vaginal Atrophy/Menopausal

Vaginal Tissue Regeneration

Regenerative therapy for vaginal atrophy that promotes tissue rejuvenation, improves elasticity and moisture, and restores comfortable sexual function.

78%
Improvement Rate
6-10
Weeks Protocol
3-5
Treatment Sessions
Significant
Results

Clinical Rationale

Our vaginal atrophy protocol targets the atrophic changes in vaginal tissue through collagen stimulation, improved vascularization, enhanced epithelial thickness, and restoration of natural lubrication mechanisms, addressing both the structural and functional aspects of menopausal changes.

Treatment Benefits

Tissue Rejuvenation
Improved Moisture
Enhanced Elasticity
Comfort Restoration
Evidence-Based
Age-related libido decline treatment

Age-Related Libido Decline

Hormonal & Neurological Optimization

Comprehensive approach to age-related libido decline that addresses hormonal balance, neurological factors, and overall sexual wellness.

70%
Improvement Rate
8-12
Weeks Protocol
4-6
Treatment Sessions
Holistic
Approach

Clinical Rationale

Our libido enhancement protocol addresses the multifactorial nature of age-related sexual desire changes, including hormonal shifts, neurotransmitter balance, vascular health, and psychological factors, through integrated regenerative and metabolic optimization strategies.

Treatment Benefits

Increased Desire
Hormonal Balance
Improved Response
Sexual Wellness
Evidence-Based
Hormonal optimization treatment

Hormonal Optimization

Endocrine System Balance

Integrated hormonal optimization protocol that addresses sex hormone balance, thyroid function, and adrenal health for comprehensive sexual wellness.

75%
Balance Improvement
12-16
Weeks Protocol
6-8
Treatment Sessions
Systemic
Benefits

Clinical Rationale

Our hormonal optimization protocol takes a comprehensive approach to endocrine health, addressing the interconnected systems of sex hormones, thyroid function, adrenal output, and metabolic factors that collectively influence sexual function, desire, and overall vitality.

Treatment Benefits

Hormonal Balance
Improved Energy
Sexual Function
Overall Vitality
Evidence-Based
Orgasmic dysfunction treatment

Orgasmic Dysfunction

Neurological & Vascular Enhancement

Specialized regenerative approach for orgasmic dysfunction that enhances neurological pathways, improves blood flow, and supports the complete sexual response cycle.

65%
Improvement Rate
10-14
Weeks Protocol
5-7
Treatment Sessions
Comprehensive
Approach

Clinical Rationale

Our orgasmic dysfunction protocol addresses the complex neurological, vascular, and psychological components of orgasm, enhancing neural transmission, improving genital blood flow, supporting pelvic muscle function, and addressing the multifaceted nature of orgasmic response.

Treatment Benefits

Improved Orgasm
Enhanced Sensation
Better Response
Sexual Satisfaction
Evidence-Based
Facial skin rejuvenation treatment

Facial Skin Rejuvenation

Texture & Radiance Restoration

Comprehensive regenerative protocol for facial skin utilizing UC-MSC conditioned media with exosomes and growth factors to improve texture, enhance radiance, and promote overall skin health through natural cellular activation.

↑47%
Collagen Increase
4-6
Weeks Results
3-4
Treatment Sessions
None
Downtime

Clinical Rationale

UC-MSC conditioned media demonstrates superior efficacy compared to adipose-derived sources in increasing skin thickness and collagen density through paracrine signaling via TGF-β1, bFGF, VEGF, and exosomal transfer of regenerative microRNAs. Our protocol stimulates fibroblast activity and enhances cellular turnover for comprehensive skin restoration.

Treatment Benefits

Improved Texture
Enhanced Radiance
Pore Refinement
Natural Glow
Evidence-Based
Phase 3 Clinical Trial
IRB-Approved Protocol
Psoriasis treatment

Psoriasis Management

Immune Modulation Therapy

Targeted immunomodulatory therapy for plaque psoriasis utilizing UC-MSC secretome to regulate T-cell activity, reduce inflammatory cytokine cascades, and restore normal keratinocyte differentiation.

47.1%
≥40% PASI Improvement
4-8
Week Protocol
3-6
Treatments
None
Downtime

Clinical Rationale

In a clinical trial of 17 psoriasis patients, 47.1% achieved ≥40% improvement in PASI score following UC-MSC infusion. The therapy modulates the Th17/Treg balance, reduces IL-17 and IL-23 signaling, and suppresses the inflammatory cascade central to psoriatic plaque formation while promoting regulatory T-cell populations.

Treatment Benefits

Reduced Plaque Area
Decreased Scaling
Reduced Erythema
Extended Remission
Evidence-Based
Clinical Study
Eczema treatment

Atopic Dermatitis (Eczema)

Barrier Restoration Therapy

Comprehensive therapy for atopic dermatitis utilizing UC-MSC conditioned media cream to restore skin barrier function, reduce inflammation, and modulate the immune response in eczematous skin.

↑15 AU
Skin Hydration
↓15 g/m²/h
Water Loss
4-6
Week Protocol
Topical
Application

Clinical Rationale

In a clinical study of 28 atopic dermatitis patients, UC-MSC conditioned media cream significantly improved skin hydration by 15 arbitrary units and reduced transepidermal water loss by 15 g/m²/h. The therapy restores filaggrin expression, reduces Th2-mediated inflammation, and supports regeneration of the compromised skin barrier.

Treatment Benefits

Reduced Itching
Improved Hydration
Barrier Restoration
Reduced Erythema
Evidence-Based
Dual-Action Therapy
Inflammatory dermatoses treatment

Combination Inflammatory Dermatoses

Comprehensive Immune Modulation

Advanced immunomodulatory protocol for complex inflammatory skin conditions combining UC-MSC systemic and topical approaches to address both local inflammation and systemic immune dysregulation.

52%
Response Rate
6-10
Week Protocol
4-8
Treatments
None
Downtime

Clinical Rationale

UC-MSCs address inflammatory dermatoses through multiple mechanisms: induction of M2 macrophage polarization, reduction of mast cell infiltration, downregulation of Th17 and Th2 responses, and restoration of normal keratinocyte differentiation. This comprehensive approach addresses both the immune dysregulation and epithelial dysfunction characteristic of chronic inflammatory skin conditions.

Treatment Benefits

Immune Modulation
Barrier Repair
Reduced Inflammation
Long-term Remission
Evidence-Based
Hair loss treatment

Hair Loss

Regenerative Hair Restoration

Advanced cellular therapy for hair loss utilizing UC-MSC derived exosomes that stimulate follicle regeneration, improve hair density, and promote natural hair growth through growth factor activation and dermal papilla cell stimulation.

↑30%
Hair Density
12-16
Weeks Results
3-4
Treatment Sessions
Minimal
Downtime

Clinical Rationale

MSC-derived exosomes (including Bio-Pulsed avian MSC-sEVs and UC-MSC conditioned media) stimulate dermal papilla cells, improve anagen/telogen ratio, and reduce hair shedding. Our protocol activates dormant hair follicles, extends the anagen (growth) phase, and improves microcirculation to follicle beds.

Treatment Benefits

Follicle Regeneration
Increased Density
Natural Growth
Non-Surgical
Evidence-Based
Clinical Study
Post-acne scar treatment

Post-Acne Scar Reduction

Scar Tissue Remodeling

Advanced regenerative therapy for post-acne scarring utilizing MSC-conditioned media and MSC-derived exosomes to promote tissue remodeling, improve skin surface, and reduce scar visibility.

78%
Improvement Rate
8-12
Weeks Protocol
4-6
Treatment Sessions
Progressive
Results

Clinical Rationale

Clinical studies demonstrate that MSC-conditioned media and exosomes combined with microneedling or fractional CO2 laser stimulate collagen remodeling and improve skin texture in atrophic acne scarring. Our protocol targets disorganized collagen and fibrotic tissue, promoting healthy collagen remodeling and normalizing dermal architecture.

Treatment Benefits

Scar Softening
Texture Improvement
Color Evening
Confidence Boost
Evidence-Based
Clinical Trial Data
Wound healing treatment

Wound Healing Support

Tissue Repair Acceleration

Advanced regenerative protocol utilizing UC-MSCs and their derivatives that accelerates wound healing, reduces scarring, and promotes optimal tissue repair and regeneration through paracrine action.

100%
Healing Rate (3mo)
2-4
Weeks Protocol
2-4
Treatment Sessions
Rapid
Response

Clinical Rationale

In a clinical trial of 53 patients with diabetic foot ulcers, UC-MSCs administered around ulcers resulted in significant new blood vessel formation after 3 months, with ulcers healing completely or gradually. UC-MSCs accelerate healing through paracrine action, promoting epithelialization, granulation tissue formation, collagen deposition, and angiogenesis via the PI3K/Akt pathway.

Treatment Benefits

Faster Healing
Reduced Scarring
Better Outcomes
Tissue Quality

Live Chat Free Consultation